Table 4. Characteristics and Clinical... | American Society of Hematology

Table 4.

Characteristics and Clinical Outcomes of Ph⁺ Adult ALL

No.	Ph (%)	Median Age (yr)	Median WBC Count	CR (%)	CRD (mo)	MST (mo)	References
334	12	46% > 50	34% > 50	56	9	11	Preti et al84
15	50	26.5	89.5	50	5-10	7.5	Bloomfield et al85
113	20	39.7	73.3	63.6	NA	7	Secker-Walker et al80
56	30	39	26.3	71	10	11.2	Westbrook et al73
56	26.8	39	12^3-150	73.3^3-150	6	NA	Specchia et al86
443	29	45	30	59	NA^3-151	NA	GFCH7
58	21	51	57	75	8.5	NA	Fenaux et al8
350	11	NA	NA	83	NA	NA^3-152	UKALL XA¹⁰
172	17	35	24	46	7	11	TIWCL^18,37^3-153

No.	Ph (%)	Median Age (yr)	Median WBC Count	CR (%)	CRD (mo)	MST (mo)	References
334	12	46% > 50	34% > 50	56	9	11	Preti et al84
15	50	26.5	89.5	50	5-10	7.5	Bloomfield et al85
113	20	39.7	73.3	63.6	NA	7	Secker-Walker et al80
56	30	39	26.3	71	10	11.2	Westbrook et al73
56	26.8	39	12^3-150	73.3^3-150	6	NA	Specchia et al86
443	29	45	30	59	NA^3-151	NA	GFCH7
58	21	51	57	75	8.5	NA	Fenaux et al8
350	11	NA	NA	83	NA	NA^3-152	UKALL XA¹⁰
172	17	35	24	46	7	11	TIWCL^18,37^3-153

Abbreviation: NA, not available.

Not significantly different from Ph⁻ ALL.

Five months median DFS.

13% DFS at 3 years.

Includes data from Bloomfield et al.18